Finance

Lists
Why is INO up ၆.၉၄%?
Dive Deeper
INO:NASDAQ
Inovio Pharmaceuticals Inc
၀.၉၀ US$
+၆.၉၄%
(+၀.၀၅၈) 1D
၀.၉၁ US$
+၁.၄၂% (+၀.၀၁၃)
After hours
Closed: အောက် ၂၃, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INO...
Open
၀.၈၅ US$
High
၀.၉၄ US$
Low
၀.၈၀ US$
Mkt. cap
၉.၂၆ ကုဋေ
Avg. vol.
၃.၅၁ သန်း
Volume
၃.၉၃ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၁.၁၇ US$
Beta
၁.၆၁
Shares outstanding
၁၀.၃၄ ကုဋေ
No. of employees
၁၁၂
Open
၀.၈၅ US$
High
၀.၉၄ US$
Low
၀.၈၀ US$
Mkt. cap
၉.၂၆ ကုဋေ
Avg. vol.
၃.၅၁ သန်း
Volume
၃.၉၃ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၁.၁၇ US$
Beta
၁.၆၁
Shares outstanding
၁၀.၃၄ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
News Corp
News Corp
·
ပြီးခဲ့သည့် ၁၀ နာရီ
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees၁၁၂
Founded၁၉၉၉
Headquarters-
Sector-
Websiteinovio.com
Analyst ratings
Based on 3 analysts giving stock ratings to INO in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for INO in the last 3 months.
Highest
Current ၀.၉၀ US$
၄.၀၀ US$ (+၃၄၅.၈၈%)
Average
၃.၁၇ US$ (+၂၅၃.၃၆%)
Lowest
၂.၅၀ US$ (+၁၇၈.၆၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Tenthoff
Piper Sandler
Buy
Reiterated
၄.၀၀ US$
+၃၄၅.၉%
10/21/2026
Roger Song
Jefferies
Buy
Upgraded
၃.၀၀ US$
+၂၃၄.၄%
08/12/2026
Ram Selvaraju
H.C. Wainwright
Hold
Reiterated
၂.၅၀ US$
+၁၇၈.၇%
08/13/2026
Hartaj Singh
Oppenheimer
Buy
Maintained
၁၃.၀၀ US$
+၁,၃၄၉.၁%
11/11/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၁.၃၃ ကုဋေ
၁.၀၃ ကုဋေ
၁.၄၁ ကုဋေ
၁.၀၈ ကုဋေ
Cost of revenue
၁.၃၃ ကုဋေ
၁.၀၃ ကုဋေ
၁.၄၁ ကုဋေ
၁.၀၈ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၇.၈၈ သန်း
၇.၂၂ သန်း
၇.၈၈ သန်း
၇.၈၀ သန်း
Operating expense
၇.၈၈ သန်း
၇.၂၂ သန်း
၇.၈၈ သန်း
၇.၈၀ သန်း
Total operating expenses
၂.၁၂ ကုဋေ
၁.၇၅ ကုဋေ
၂.၁၉ ကုဋေ
၁.၈၆ ကုဋေ
Operating income
-၂.၁၂ ကုဋေ
-၁.၇၅ ကုဋေ
-၂.၁၉ ကုဋေ
-၁.၈၆ ကုဋေ
Other non operating income
-၂.၄၃ ကုဋေ
၂.၁၂ ကုဋေ
၄.၁၄ သန်း
၁.၂၇ ကုဋေ
EBT including unusual items
-၄.၅၅ ကုဋေ
၃.၇၆ သန်း
-၁.၉၇ ကုဋေ
-၆.၀၁ သန်း
EBT excluding unusual items
-၄.၅၅ ကုဋေ
၃.၇၅ သန်း
-၁.၉၅ ကုဋေ
-၅.၅၃ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၄.၅၅ ကုဋေ
၃.၇၆ သန်း
-၁.၉၇ ကုဋေ
-၆.၀၁ သန်း
Net profit margin
-
-
-
-
Earnings per share
-၀.၈၇
-၀.၂၈
-၀.၃၁
-၀.၂၄
Interest and investment income
၅.၅၂ သိန်း
၄.၄၉ သိန်း
၄.၄၀ သိန်း
၃.၆၄ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၅.၅၂ သိန်း
၄.၄၉ သိန်း
၄.၄၀ သိန်း
၃.၆၄ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၂.၀၉ ကုဋေ
-၁.၇၁ ကုဋေ
-၂.၁၆ ကုဋေ
-၁.၈၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ